HSBC HOLDINGS PLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q1 2021$435,000
-2.2%
3,186
-8.7%
0.00%0.0%
Q4 2020$445,000
+4.5%
3,488
-6.7%
0.00%0.0%
Q3 2020$426,000
-4.7%
3,737
-26.0%
0.00%0.0%
Q1 2020$447,000
+10.1%
5,049
-33.6%
0.00%0.0%
Q4 2019$406,000
+95.2%
7,609
+44.8%
0.00%
Q3 2019$208,000
-11.1%
5,254
-7.7%
0.00%
Q2 2019$234,000
+6.8%
5,691
+21.4%
0.00%
Q1 2019$219,0004,6890.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders